Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/STRO/Capital expenditures

SUTRO BIOPHARMA, INC. (STRO) Capital expenditures 2016–2018

SUTRO BIOPHARMA, INC. (STRO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.

$1.6MFY2018 · since FY2016: $4.4M → $1.6M
161718
Fiscal yearValueYoY
FY2018$1.6M-53.0%
FY2017$3.3M-24.5%
FY2016$4.4M—

Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.

Source: SEC XBRL filings · For reference only · Not investment advice

More STRO financial trends

STRO RevenueSTRO Net incomeSTRO Net marginSTRO Gross profitSTRO Gross marginSTRO Operating incomeSTRO Operating marginSTRO Operating cash flowSTRO Free cash flowSTRO Return on equitySTRO Stock buybacksSTRO Dividends paidSTRO Total assetsSTRO Total liabilitiesSTRO Shareholders’ equitySTRO overview →